𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The ninth annual david karnofsky lecture. Treatment of acute lymphocytic leukemia

✍ Scribed by Donald Pinkel


Book ID
102665389
Publisher
John Wiley and Sons
Year
1979
Tongue
English
Weight
881 KB
Volume
43
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

✦ Synopsis


St. Jude Children's Research Hospital. The work I will present today represents 16 years of effort by the staff and employees of St. Jude, the courage and faith of children with leukemia and their families, and the generosity of our supporters. It also reflects the guidance of the man we


πŸ“œ SIMILAR VOLUMES


Vm-26 with prednisone and vincristine fo
✍ Rivera, Gaston ;Bowman, W. Paul ;Murphy, Sharon B. ;Dahl, Gary V. ;Aur, Rhomes J πŸ“‚ Article πŸ“… 1982 πŸ› John Wiley and Sons 🌐 English βš– 500 KB

## Abstract Fifty‐six children with refractory acute lymphocytic leukemia (ALL) were assessed for remission‐induction responses to VM‐26 (250 mg/m^2^ per week) in combination with prednisone (40 mg/m^2^ per day) and vincristine (1.5 mg/m^2^ per week). Each child had been treated intensively with st

Fludarabine and cytosine arabinoside in
✍ Samer Suki; Hagop Kantarjian; Varsha Gandhi; Elihu Estey; Susan O'Brien; Milosla πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 571 KB

## Background: The objectives of the study were to evaluate the antileukemic efficacy and toxicity profiles of the combination of fludarabine and intermediate-dose cytosine arabinoside (ara-c) in refractory or relapsed adult acute lymphocytic leukemia (all). patients and methods. thirty adults with

Mitoxantrone and high-dose cytosine arab
✍ Hagop M. Kantarjian; Ronald L. Walters; Michael J. Keating; Elihu H. Estey; SUSA πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 447 KB πŸ‘ 2 views

Twenty-five adult patients with refractory acute lymphocytic leukemia received salvage therapy with mitoxantrone 5 mg/m2 intravenously over 1 hour daily for 5 days and cytosine arabinoside 3 g/m2 intravenously over 2 hours every 12 hours for six doses. Overall, nine patients (36%) achieved complete